# Validation of Biomarkers for Long COVID in the LIINC Viral Immunopathogenesis and Persistence Repeat Donor Cohort (VIPER)

> clinical trial · VERIFIED · 2026-08-18

Status: RECRUITING · Sponsor: University of California, San Francisco · Condition: Long Covid

- Company: University of California, San Francisco
- Sector: diagnostics
- Primary source: https://clinicaltrials.gov/study/NCT07770022

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.